Urban Supreme System

After leaving Tianya Jewelry Store, Su Zhe received another call from Li Changhua. ````

Li Changhua informed Su Zhe that the funds from Changhua Pharmaceutical were now in place and could be transferred to his account immediately.

In addition to this news, Li Changhua also has another good news to tell Su Zhe.

That is the clinical trial of the blue elixir. It has now ended successfully. Everything went very smoothly. The results of this last clinical trial were perfect, far exceeding the original plan.

After the clinical trial of the blue elixir is completed, the approval document from the Food and Drug Administration will be issued soon, so the blue elixir can be officially put into production soon.

This is definitely great news for Changhua Pharmaceutical, and Su Zhe is very happy for this.

Su Zhe didn't expect that today's surprises would come one after another, and that there would be so much good news today.

First, Tianya Jewelry Store raised enough funds in two days to settle the balance of the transaction, which already made Su Zhe very happy.

Unexpectedly, Changhua Pharmaceutical also prepared 500 million in cash for Su Zhe today, and it would be available immediately.

The most important thing is that even the clinical trial of Blue Spirit Medicine has passed perfectly today, and the approval document from the Food and Drug Administration will follow. This is crucial to Changhua Pharmaceutical.

Today's good news came one after another, making Su Zhe feel a little overwhelmed.

Now with Changhua Pharmaceutical's 500 million, Su Zhe has 1.13 billion. Now it is only 370 million short of the 1.5 billion, and it is getting closer and closer to the goal.

And because the blue elixir passed clinical trials. It also gave Su Zhe a new idea now.

This 370 million. Now Su Zhe has a way to raise it in his mind. Maybe if you succeed, you might get more.

If possible, Su Zhe certainly hopes that he can raise more money and acquire more shares, so as to relieve Yan Yuyan's pressure and allow her to have more funds for turnover.

Now that the clinical trial of the blue elixir has been successful, Su Zhe has the confidence to want this newly successful blue elixir. Go get some money.

…

Two days later,

Su Zhe came to Guanzhou City again.

The reason why Su Zhe came to Guanzhou City today was mainly for two things.

The first thing Su Zhe did was to inspect Guanzhou Xinjing Pharmaceutical. Now all the acquisition procedures have been completed, and Guanzhou Xinjing Pharmaceutical is now a subsidiary of Changhua Pharmaceutical.

Now Guanzhou Xinjing Pharmaceutical and Changhua Pharmaceutical have entered the integration stage. Once the integration is completed, the blue elixir that will be launched will be produced at Guanzhou Xinjing Pharmaceutical.

This is mainly due to the output of Changhua Pharmaceutical. It has reached its limit and it is difficult to free up the production line to produce blue elixir. If you insist on forcing Changhua Pharmaceutical to produce blue elixir, that is possible, but you will need to reduce the production of Thiefoling and other drugs.

But since Guanzhou Xinjing Pharmaceutical is already a subsidiary of Changhua Pharmaceutical, there is no need to worry so much. Just let Guanzhou Xinjing Pharmaceutical produce the blue elixir.

Moreover, when the production of Thielsin, Mianbiling, and Xingshen tablets needs to be increased, they will also be produced at Guanzhou Xinjing Pharmaceutical.

Because Guanzhou Xinjing Pharmaceutical generally focuses on OEM and rarely produces its own drugs, most of the OEM agreements between Guanzhou Xinjing Pharmaceutical and other pharmaceutical factories have ended and have not been renewed. Made an appointment.

It was also for this reason that Zhan Xin was unable to continue to maintain Guanzhou Xinjing Pharmaceutical and had no choice but to be acquired.

But now that Changhua Pharmaceutical has taken over Guanzhou Xinjing Pharmaceutical, it will naturally no longer engage in OEM business. In the future, Guanzhou Xinjing Pharmaceutical will only produce its own drugs.

Therefore, because Guanzhou Xinjing Pharmaceutical currently does not have a main business, the integration with Changhua Pharmaceutical is very simple and the process is very smooth. I believe it will not take long to complete the integration and officially merge into Changhua Pharmaceutical. middle.

Su Zhe came here today to inspect the integration work. This was the first thing he did when he came to Guanzhou City.

However, this matter was only minor, because Li Changhua supervised the entire integration work, so Su Zhe didn't need to worry about it at all. Su Zhe just stopped by to take a look.

Su Zhe came to Guanzhou City today mainly for the second thing, which was for Yadai Group.

Because Yan Yuyan and Shen Chuxia had already contacted other shareholders of Yadai Group for Su Zhe and had negotiated with them, several other shareholders had agreed to sell their shares.

Therefore, Su Zhe came to Guanzhou City today to acquire shares of Yadai Group.

The reason why Su Zhe came to acquire the shares of Yadai Group today is of course because he has raised enough funds, so he came here.

Su Zhe now has 2.63 billion in his account.

Of the 2.63 billion, 500 million was the money Tianya Jewelry Store paid to buy jade, and the other 500 million was the payment paid in advance by Changhua Pharmaceutical. Su Zhe originally had 130 million. , which adds up to 1.13 billion.

The other 1.5 billion was obtained by Su Zhe through the blue elixir, which really cost him a lot of effort.

Two days ago, after the blue elixir passed the final human clinical trial, Su Zhe took action.

Su Zhe took the blue elixir experiment report and relevant documents to the bank and applied for a loan of 1.5 billion, with a term of six months.

Su Zhe used the blue elixir as collateral for this purpose, and used the blue elixir to borrow 1.5 billion from the bank.

If Su Zhe cannot repay the 1.5 billion in six months, the ownership of the blue elixir will temporarily belong to the bank. Of course, even if Su Zhe cannot repay the 1.5 billion, the bank cannot affect the production of the blue elixir.

The blue elixir will still be produced in Changhua Pharmaceutical Factory, and the bank will only intervene in the sales of the blue elixir.

It's just that the license fee for Changhua Pharmaceutical's production of blue elixir will no longer belong to Su Zhe, but to the bank, and the term is ten years.

At that time, Su Zhe and Changhua Pharmaceutical agreed that for every blue elixir produced, a license fee of RMB 1 yuan would be paid.

If Su Zhe cannot repay the bank loan within the time limit, then the money will belong to the bank in these ten years.

Based on the therapeutic effect of this blue elixir, the sales volume in the future will definitely be high, and the daily sales volume can be at least 2 million pills.

If 2 million pills are produced in a day, the license fee will be 2 million, and the production license fee for that year will be 730 million. In other words, it only takes 2 years for the bank to recover the loan of 1.5 billion, and In the remaining eight years, you will make a steady profit. (To be continued...)

...

... ()